15442-64-5
基本信息
原卟啉锌
三水合原卟啉锌
原卟啉锌(II)
三水合原卟啉锌,96%
锌原卟啉(ZNPPIX)
原卟啉 IX 锌(II) 络合物
3,3'-(3,8,13,17-四甲基-7,12-二乙烯基卟啉-2,18-二基)二丙酸锌
PROTOPORPHYRINATO ZINC
Zinc protoporphyrin trihydrate
Zinc protoporphyrin trihydrate, 95+%
PROTOPORPHYRINATO ZINC ISO 9001:2015 REACH
Zinc Protoporphyrin IX DISCONTINUED, offer Z439970
Zinc (II) Protoporphyrin IX - CAS 15442-64-5 - Calbiochem
Zinc(II) 3,3'-(3,8,13,17-tetramethyl-7,12-divinylporphyrin-2,18-diyl)dipropionate
dihydrogen [3,8,13,17-tetramethyl-7,12-divinyl-21H,23H-porphine-2,18-dipropionato(4-)-N21,N22,N23,N24]zincate(4-)
物理化学性质
RTECS号 | ZG9210300 |
储存条件 | Store at RT |
溶解度 | DMSO : 50 mg/mL (79.87 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble) |
形态 | Crystalline |
颜色 | 暗红色至紫色 |
水溶解性 | Insoluble in water. Soluble in ethanol, and DMSO, pyridine, or dimethyl formamide. |
EPA化学物质信息 | Zincate(2-), [7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-.kappa.N21,.kappa.N22,.kappa.N23,.kappa.N24]-, dihydrogen, (SP-4-2)- (15442-64-5) |
安全数据
危险性符号(GHS) | GHS07 |
警示词 | 警告 |
危险性描述 | H302-H315-H319-H335 |
防范说明 | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
WGK Germany | 3 |
TSCA | Yes |
锌原卟啉价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/08 | 032068 | 三水合原卟啉锌, 96%
Zinc protoporphyrin, 96% | 15442-64-5 | 10mg | 724元 |
2024/11/08 | 032068 | 三水合原卟啉锌, 96%
Zinc protoporphyrin, 96% | 15442-64-5 | 50mg | 2048元 |
2024/11/08 | 032068 | 原卟啉锌 Zinc protoporphyrin | 15442-64-5 | 0.25g | 8005元 |
常见问题列表
Human Endogenous Metabolite
|
Zinc Protoporphyrin (Zn(II)-protoporphyrin IX; 5 μM; 72 hours) causes the fraction of late apoptotic and necrotic cells increasing from 10.9% in controls to 30.4% after 72 h.
Zinc Protoporphyrin (1.25-40 μM; 48 or 72 hours) exerts cystostatic/cytotoxic effects against tumor cells.
Zinc Protoporphyrin (2.5, 5 μM; 48 or 72 hours) results in dose- and time-dependent reduction of cells in G1 phase of the cell cycle.
Zinc Protoporphyrin (1.25-40 μM; 48 hours) leads to accumulation of cleaved (active) caspase-3.
Apoptosis Analysis
Cell Line: | C-26 cells |
Concentration: | 5 μM |
Incubation Time: | 72 hours |
Result: | The fraction of late apoptotic and necrotic cells increased from 10.9% in controls to 30.4% after 72 h. |
Cell Cytotoxicity Assay
Cell Line: | C-26 and MDA-MB231 cells |
Concentration: | 1.25, 2.5, 5, 10, 20, 40 μM |
Incubation Time: | 48 or 72 hours |
Result: | Exerted cystostatic/cytotoxic effects against tumor cells. |
Cell Cycle Analysis
Cell Line: | C-26 cells |
Concentration: | 2.5, 5 μM |
Incubation Time: | 48 or 72 hours |
Result: | Resulted in dose- and time-dependent reduction of cells in G1 phase of the cell cycle. |
Western Blot Analysis
Cell Line: | C-26 cells |
Concentration: | 1.25, 2.5, 5, 10, 20, 40 μM |
Incubation Time: | 48 hours |
Result: | Leaded to accumulation of cleaved (active) caspase-3. |
Zinc Protoporphyrin (12.5, 25, 50 mg/kg for i.p.; 12.5, 50 mg/kg for p.o.; from day 7 to 19) exerts dose-dependent antitumor effects manifested by the retardation of tumor growth.
Animal Model: | BALB/c mice inoculated with C-26 cells |
Dosage: | 12.5, 25, 50 mg/kg for i.p.; 12.5, 50 mg/kg for p.o. |
Administration: | IP or PO; from day 7 to 19 |
Result: | Exerted dose-dependent antitumor effects manifested by the retardation of tumor growth. |